The outbreak of COVID-19 remains a global health threat and clinical laboratories and healthcare providers are facing several challenges in reducing the severity and mortality of patients who are hospitalized from the infection. One of these challenges is understanding and quantifying the severity of patient infections.^2,3

Clinical studies have shown that significantly high levels of CRP in COVID-19 patients are linked to severe acute cases, while slightly elevated to decreasing levels of CRP in COVID-19 patients are linked to mild, non-severe cases.^2,3 This association provides healthcare providers with objective and quantifiable information that can be used to assess the severity of the disease.

CRP is a widely used clinical laboratory test that is mainly used to evaluate infections, tissue injuries, and inflammatory disorders. The Centers for Disease Control and Prevention (CDC) lists CRP as a considered laboratory test for evaluating and caring for COVID-19 patients.¹ Furthermore, recent clinical studies have shown that evaluating CRP levels in COVID-19 patients can lead to proper patient transfer within different hospital departments (e.g., Intensive Care Unit vs. Isolation Ward) and can help with appropriate patient discharge.^2,3

SEKURE® CRP Ultra Wide Range

We offer a highly sensitive, ready-to-use assay for the quantitative measurement of CRP with a wide linear range of 0.05-160 mg/L so clinical laboratories can empower healthcare providers to make more informed decisions when evaluating COVID-19 patients.

Key Benefits:

• Convenience: Wide linear range allowing for low and high sample concentrations.
• Flexibility: Compatible with several sample types; serum, EDTA plasma, and lithium heparinized plasma.
• Efficiency: Liquid stable, ready-to-use reagent.